
Rafael Holdings RFL
$ 0.95
2.15%
Country |
|
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NYSE |
Shares |
51.4 M |
Market Cap[1] |
$ 48.8 M |
EBITDA (LTM) |
$ -33.3 M |
P/E (LTM) |
-1.982759 |
P/S (LTM) |
38.713449 |
EPS (LTM) |
-0.58 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
REGENXBIO
RGNX
|
$ 7.25 | 0.14 % | $ 374 M | Nasdaq Global Select Market,SPB | ||
|
Rigel Pharmaceuticals
RIGL
|
$ 42.57 | -0.82 % | $ 766 M | Nasdaq Global Select Market | ||
|
Celsion Corporation
CLSN
|
- | -6.63 % | $ 13.9 M | Nasdaq Capital Market | ||
|
Генетико
GECO
|
- | - | - | MOEX | ||
|
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market | ||
|
Tenax Therapeutics
TENX
|
$ 1.44 | 1.41 % | $ 56.5 M | Nasdaq Global Select Market | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | ||
|
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market | ||
|
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market | ||
|
SELLAS Life Sciences Group
SLS
|
$ 18.42 | -3.84 % | $ 2.01 B | Nasdaq Capital Market | ||
|
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
- | 0.74 % | $ 768 M | Nasdaq Capital Market | ||
|
Abcam plc
ABCM
|
- | - | $ 4.9 B | Nasdaq Global Select Market | ||
|
Rezolute
RZLT
|
$ 4.26 | 5.98 % | $ 443 M | Nasdaq Capital Market | ||
|
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market | ||
|
Tiziana Life Sciences PLC
TLSA
|
$ 0.8 | 23.73 % | $ 85.3 M | Nasdaq Global Market | ||
|
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market | ||
|
Affimed N.V.
AFMD
|
- | -34.95 % | $ 21.5 M | Nasdaq Global Select Market,SPB | ||
|
Vir Biotechnology
VIR
|
$ 9.14 | -1.24 % | $ 1.27 B | Nasdaq Global Select Market,SPB | ||
|
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
- | -1.58 % | $ 28.1 M | Nasdaq Global Market | ||
|
Celyad Oncology SA
CYAD
|
- | - | $ 12.5 M | Nasdaq Global Market | ||
|
Seer
SEER
|
$ 1.45 | -1.03 % | $ 80.4 M | Nasdaq Global Select Market | ||
|
Gracell Biotechnologies
GRCL
|
- | - | $ 3.37 B | Nasdaq Global Select Market | ||
|
Summit Therapeutics
SMMT
|
$ 10.49 | -1.73 % | $ 7.84 B | Nasdaq Global Select Market | ||
|
Viridian Therapeutics
VRDN
|
$ 30.1 | 0.13 % | $ 3.06 B | Nasdaq Capital Market | ||
|
Shattuck Labs
STTK
|
$ 4.48 | -2.4 % | $ 312 M | Nasdaq Global Select Market | ||
|
Silence Therapeutics plc
SLN
|
$ 19.82 | 0.08 % | $ 2.81 B | Nasdaq Global Select Market | ||
|
Soligenix
SNGX
|
$ 0.25 | -10.34 % | $ 1.3 M | Nasdaq Capital Market | ||
|
Sanofi
SNY
|
$ 47.19 | -0.73 % | $ 57.6 B | Nasdaq Global Select Market | ||
|
Spruce Biosciences
SPRB
|
$ 40.66 | 0.42 % | $ 31.2 M | Nasdaq Global Select Market | ||
|
Spero Therapeutics
SPRO
|
$ 0.87 | -3.47 % | $ 48.7 M | Nasdaq Global Select Market | ||
|
Sarepta Therapeutics
SRPT
|
$ 14.54 | -1.56 % | $ 1.46 B | Nasdaq Global Select Market,SPB | ||
|
Savara
SVRA
|
$ 4.7 | 4.8 % | $ 1.05 B | Nasdaq Global Select Market | ||
|
Teligent, Inc.
TLGT
|
- | -13.85 % | $ 16.1 M | Nasdaq Global Select Market | ||
|
Viela Bio, Inc.
VIE
|
- | - | $ 2.91 B | Nasdaq Global Select Market | ||
|
Sutro Biopharma
STRO
|
$ 8.47 | -5.04 % | $ 72 M | Nasdaq Global Select Market | ||
|
Tarsus Pharmaceuticals
TARS
|
$ 75.97 | -2.85 % | $ 3.17 B | Nasdaq Global Select Market | ||
|
Supernus Pharmaceuticals
SUPN
|
$ 36.28 | 1.88 % | $ 2.05 B | Nasdaq Global Select Market,SPB | ||
|
TG Therapeutics
TGTX
|
$ 66.13 | 5.45 % | $ 9.54 B | Nasdaq Capital Market | ||
|
Aphria Inc.
APHA
|
- | -0.45 % | $ 4.87 B | Nasdaq Global Select Market | ||
|
Aerpio Pharmaceuticals, Inc.
ARPO
|
- | -0.90 % | $ 104 M | Nasdaq Capital Market | ||
|
Chiasma, Inc.
CHMA
|
- | -6.00 % | $ 238 M | Nasdaq Global Select Market | ||
|
Adamas Pharmaceuticals, Inc.
ADMS
|
- | - | $ 376 M | Nasdaq Global Market | ||
|
Cellect Biotechnology Ltd.
APOP
|
- | 0.38 % | $ 12.9 M | Nasdaq Global Select Market | ||
|
AzurRx BioPharma, Inc.
AZRX
|
- | 2.07 % | $ 34.4 M | Nasdaq Capital Market | ||
|
Cerecor Inc.
CERC
|
- | -1.68 % | $ 283 M | Nasdaq Capital Market | ||
|
Constellation Pharmaceuticals, Inc.
CNST
|
- | - | $ 1.63 B | Nasdaq Global Select Market | ||
|
Auris Medical Holding Ltd.
EARS
|
- | -1.77 % | $ 39.2 M | Nasdaq Capital Market | ||
|
Dicerna Pharmaceuticals, Inc.
DRNA
|
- | 0.34 % | $ 2.98 B | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.